328
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Quercetin-containing self-assemble proliposome preparation and evaluation

, , &
Pages 335-342 | Received 07 Jun 2016, Accepted 19 Sep 2016, Published online: 18 Oct 2016

References

  • Abdelbary G, Fahmy RH. (2009). Diazepam-loaded solid lipid nanoparticles: design and characterization. AAPS PharmSciTech 10:211–19.
  • Alexopoulou E, Georgopoulos A, Kagkadis KA, Demetzos C. (2006). Preparation and characterization of lyophilized liposomes with incorporated quercetin. J Liposome Res 16:17–25.
  • Bobbala SK, Veerareddy PR. (2012). Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery. J Liposome Res 22:285–94.
  • Cai X, Fang Z, Dou J, et al. (2013). Bioavailability of quercetin: problems and promises. Curr Med Chem 20:2572–82.
  • Chitkara D, Nikalaje SK, Mittal A, et al. (2012). Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model. Drug Deliv Transl Res 2:112–23.
  • Cui M, Wu W, Hovgaard L, et al. (2015). Liposomes containing cholesterol analogs of botanical origin as drug delivery systems to enhance the oral absorption of insulin. Int J Pharm 489:277–84.
  • Desai MP, Labhasetwar V, Amidon GL, Levy RJ. (1996). Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13:1838–45.
  • Duangjit S, Pamornpathomkul B, Opanasopit P, et al. (2014). Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes. Int J Nanomedicine 9:2005–17.
  • Elhissi A, Gill H, Ahmed W, Taylor K. (2011). Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology. J Liposome Res 21:173–80.
  • Elhissi AM, Karnam KK, Danesh-Azari MR, et al. (2006). Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers. J Pharm Pharmacol 58:887–94.
  • Galović Rengel R, Barisić K, Pavelić Z, et al. (2002). High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. Eur J Pharm Sci 15:441–8.
  • Gang W, Jie WJ, Ping ZL, et al. (2012). Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo. Expert Opin Drug Deliv 9:599–613.
  • Hädrich G, Monteiro SO, Rodrigues MR, et al. (2016). Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies. Drug Dev Ind Pharm 42:1165–73.
  • Hanke U, May K, Rozehnal V, et al. (2010). Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2). Eur J Pharm Biopharm 76:260–8.
  • Ibrahim WM, AlOmrani AH, Yassin AE. (2014a). Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability. Int J Nanomedicine 9:129–44.
  • Ibrahim MM, Tawfique SAH, Mahmoud MM. (2014b). Liposomal diltiazem HCl as ocular drug delivery system for glaucoma. Drug Dev Ind Pharm 40:765–73.
  • Janga KY, Jukanti R, Velpula A, et al. (2012). Bioavailability enhancement of zaleplon via proliposomes: role of surface charge. Eur J Pharm Biopharm 80:347–57.
  • Jangde R, Singh D. (2016). Preparation and optimization of quercetin-loaded liposomes for wound healing, using response surface methodology. Artif Cells Nanomed Biotechnol 44:635–41.
  • Jeon S, Cha YY, Soo NP. (2015). Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by Layer-by-Layer electrostatic deposition for quercetin delivery. Colloids Surf B Biointerfaces 129:7–14.
  • Jukanti R, Sheela S, Bandari S, Veerareddy PR. (2011). Enhanced bioavailability of exemestane via proliposomes based transdermal delivery. J Pharm Sci 100:3208–22.
  • Karn PR, Jin SE, Lee BJ, et al. (2014). Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method. Int J Nanomedicine 9:5079–91.
  • Khan I, Yousaf S, Subramanian S, et al. (2015). Proliposome powders prepared using a slurry method for the generation of beclomethasone dipropionate liposomes. Int J Pharm 496:342–50.
  • Landi-Librandi AP, Chrysostomo TN, Caleiro Seixas Azzolini AE, et al. (2012). Study of quercetin-loaded liposomes as potential drug carriers: in vitro evaluation of human complement activation. J Liposome Res 22:89–99.
  • Lian T, Ho R. (2001). Trends and developments in liposome drug delivery systems. J Pharm Sci 90:667–80.
  • Ling SS, Magosso E, Khan NA, et al. (2006). Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Dev Ind Pharm 32:335–45.
  • Liu D, Hu H, Lin Z, et al. (2013). Quercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo. J Photochem Photobiol B Biol 127:8–17.
  • Park SN, Lee MH, Kim SJ, Yu ER. (2013). Preparation of quercetin and rutin-loaded ceramide liposomes and drug-releasing effect in liposome-in-hydrogel complex system. Biochem Biophys Res Commun 435:361–6.
  • Pavelić Z, Skalko-Basnet N, Jalsenjak I. (2005). Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis. Int J Pharm 301:140–8.
  • Perrett S, Golding M, Williams WP. (1991). A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes. J Pharm Pharmacol 43:154–61.
  • Rojanarat W, Changsan N, Tawithong E, et al. (2011). Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies. Int J Mol Sci 12:4414–34.
  • Tavano L, Muzzalupo R, Picci N, de Cindio B. (2014). Co-encapsulation of antioxidants into niosomal carriers: gastrointestinal release studies for nutraceutical applications. Colloids Surf B Biointerfaces 114:82–8.
  • Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60.
  • Tran TH, Guo Y, Song D, et al. (2014). Quercetin-containing self-Nanoemulsifying drug delivery system for improving oral bioavailability. J Pharm Sci 103:840–52.
  • Velpula A, Jukanti R, Janga KY, et al. (2013). Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge. Drug Dev Ind Pharm 39:1895–906.
  • Wong MY, Chiu GN. (2010). Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment. AntiCancer Drugs 21:401–10.
  • Xie Y, Zeng X, Li G, et al. (2010). Assessment of intestinal absorption of total flavones of Hippophae rhamnoides L. in rat using in situ absorption models. Drug Dev Ind Pharm 36:787–94.
  • Yang G, Zhao Y, Zhang Y, et al. (2015). Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo. Int J Nanomedicine 10:6633–44.
  • Zhang JH, Zhu JB. (1999). A novel method to prepare liposomes containing amikacin. J Microencapsul 16:511–16.
  • Zhao G, Zou L, Wang Z, et al. (2011). Pharmacokinetic profile of total quercetin after single oral dose of tartary buckwheat extracts in rats. J Agric Food Chem 59:4435–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.